Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

KRS Global Biotechnology, Inc. : Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products Due to Lack of Assurance of Sterility

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 01:32pm EDT

KRS Global Biotechnology, Inc. is voluntarily recalling all lots of unexpired human and animal drugs intended to be sterile to the consumer level. The products are being recalled due to lack of assurance of sterility.

Administration of a drug product intended to be sterile that is not sterile could result in serious infections which may be life-threatening. To date, KRS Global Biotechnology, Inc. has not received any reports of adverse events related to this recall.

The affected products are listed below and include a lot number and expiration date. The products can be identified by a KRS Global Biotechnology, Inc. label. Products were distributed nationwide to hospitals, doctor’s offices, surgical centers, pharmacies, veterinarians and patients.

KRS Global Biotechnology, Inc. is notifying its customers by mail, telephone, or email and is arranging for credit of all recalled products.

Health Care Providers that have these products which are being recalled should stop using them and return to KRS Global Biotechnology, Inc.

Consumers that have these products which are being recalled should stop using them and contact their doctor or health care provider.

Consumers with questions regarding this recall can contact KRS Global Biotechnology, Inc. by phone 888-398-9950 or recall@krsbio.com. We are available Monday through Friday from 9 AM to 5 PM EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using these drug products.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

To report adverse events in animals, follow the instructions for submitting an electronic Form FDA 1932a at www.fda.gov/reportanimalAE.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


© Business Wire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
06:47aCSTONE PHARMACEUTICALS : Voluntary announcement - cstone announces preliminary results from phase i trial of cs1002 demonstrating characteristics comparable to ipilimumab
PU
06:42aCSTONE PHARMACEUTICALS : Voluntary announcement - cstone announces promising orr, anti-tumor activity and safety data with its anti-pd-l1 antibody cs1001 in msi-h/dmmr solid tumors
PU
06:32aVCREDIT : Interim Report 2019
PU
06:32aEVERGREEN PRODUCTS : Connected transaction issue of new shares to a connected person under specific mandate
PU
06:27aEVERGREEN PRODUCTS : Placing of existing shares and top-up subscription of new shares
PU
06:22aCHINA SAITE : Inside information
PU
06:22aYESTAR HEALTHCARE : Next Day Disclosure Returns
PU
06:17aORIENTAL WEAVERS : Introduces new alternatives to chinese rug imports for ny buyers
PU
06:17aSINO I TECHNOLOGY : List of Directors and their Role and Function
PU
06:12aQILU EXPRESSWAY : (1) proposed re-election and election of directors; (2) proposed re-election and election of supervisors; and (3) closure period of register of members
PU
Latest news "Companies"